GLP-1, GIP, glucagon and amylin biology, with approved medicines separated from investigational molecules.
ENGLISH · EVIDENCE-FIRST SCIENCE
Evidence before
claims
Understand peptide and metabolic science through traceable human evidence, preclinical boundaries, safety context and jurisdiction-specific regulatory status.
QUICK ANSWER · REVIEWED 23 AUGUST 2026
What does PrimeCoreBio do?
It helps international readers distinguish what is known from what remains uncertain before interpreting a product, molecule or health claim.
- IdentityConfirm the molecule, formulation, product and potentially confusing names.
- EvidenceSeparate controlled human evidence from animal, cell and mechanistic research.
- RegulatoryState the product, country, indication and population whenever approval is discussed.
RESEARCH TOPICS
Start with the scientific context
Six hubs explain mechanism, evidence level and limitations before individual molecule profiles.
GHRH analogues, GH secretagogues and endocrine signalling, with biomarkers separated from clinical outcomes.
Human, animal, cell and route-specific evidence for molecules associated with tissue-repair claims.
Mitochondrial peptides, cofactors and small molecules assessed without treating them as one category.
Human evidence, formulation and country-specific regulatory status for neuropeptide research.
Cell, animal, biomarker and human-longevity evidence kept clearly separated.
THAILAND · PRODUCT EVIDENCE
Four product-specific English profiles
Thai FDA status is interpreted by exact product and indication. These are educational reference pages, not product listings.
Ozempic
Semaglutide
Read English profile →Rybelsus
Semaglutide
Read English profile →Wegovy
Semaglutide
Read English profile →Mounjaro
Tirzepatide
Read English profile →EDITORIAL METHOD
Confidence comes from showing where every conclusion comes from.
Answer first
Give the bounded answer before background detail.
Evidence separated
Regulatory, human, animal, cell and hypothesis are not interchangeable.
Jurisdiction specific
Approval always names the country, product and indication.
Limitations visible
Unknowns and review dates remain visible.
